DGAP-News

AURELIUS Group sells ISOCHEM Hungarian subsidiary Framochem

DGAP-News: AURELIUS AG / Key word(s): Disposal
AURELIUS Group sells ISOCHEM Hungarian subsidiary Framochem

01.08.2014 / 07:00

---------------------------------------------------------------------

AURELIUS Group sells ISOCHEM Hungarian subsidiary Framochem

- Sale to strategic investor from the United States following acquisition
in 2010 and successful restructuring

- Capital employed multiplied

- Already third successful exit in 2014, transaction pipeline remains
well filled

Munich, August 1, 2014 - ISOCHEM S.A.S, a company of the Munich-based
AURELIUS Group (ISIN DE000A0JK2A8), has sold its Hungary-based subsidiary
Framochem Kft together with its Germany-based sales unit ISOCHEM
Deutschland GmbH to VanDeMark Chemical Inc. headquartered in Lockport, NY,
USA. Acquired from the French state-owned enterprise SNPE in 2010, ISOCHEM
is a leading supplier of fine chemicals to customers in the pharmaceuticals
industry, cosmetics, and the specialty and agrochemical industries.
Framochem, which does not form part of ISOCHEM's core business, generated
revenues of EUR 27.1 million and an operating profit (EBITDA) of around EUR
5.9 million in 2013.

Framochem is one of the biggest independent producers of phosgene-based
fine chemicals in the world. Its products are used in a wide range of
highly attractive fields, including medication, agrochemicals,
entertainment electronics and lithium-ion batteries for the automotive
industry. Over recent years, the Hungarian subsidiary has been successfully
set up as an independent activity and realigned. Besides spending on
research and development, the focus was on producing and distributing
value-added products and expanding the customer base. All in all, this
helped to secure major improvements to operations and an increase in
revenues of over 20 percent since the acquisition. The sales proceeds will
have a very positive impact on results in the third quarter of 2014.

The buyer is VanDeMark Chemical Inc., a portfolio company of the US-based
private equity investor Uni-World Capital, L.P. The acquisition will give
it access to a much broader customer base and enable it to significantly
increase its revenues. Together, the companies will become a leading global
player in this field. "The disposal represents another great transaction.
Everyone involved will benefit greatly from the move," comments Donatus
Albrecht, the member of the AURELIUS Executive Board responsible for M&A
activities. "Our pipeline is very well filled on both the acquisition and
exit side for the second half of the year as well. 2014 is set to be yet
another record year for AURELIUS."

A telephone conference is being held in English for interested investors
and journalists at 2pm on Tuesday, August 5, 2014. The Management Board of
AURELIUS AG will report on the sale of Framochem and the present busy
period of transaction activity.

Please send us an email to [e-mail] to register.

ABOUT AURELIUS
AURELIUS has been successfully operating in the international market for
company acquisitions for many years. The focus is on companies and
corporate spin-offs in markets with plenty of potential for development.
Once under the AURELIUS umbrella, the acquisitions are given a long-term
strategic orientation and their potential developed. Building on active
operational support, the subsidiaries benefit from the management
experience and financial strength of the parent company. This is what makes
AURELIUS a "good home" for companies and their employees.
At present, the AURELIUS Group encompasses 20 subsidiaries around the globe
with facilities in Europe, Asia and the United States. Among others, these
include traditional names like Blaupunkt and Berentzen together with
numerous industrial enterprises. Companies are acquired in accordance with
strict investment criteria, although there is no specific industry focus.
Shares of AURELIUS AG are listed in the m:access segment of the Munich
Stock Exchange and are traded on all German stock exchanges under ISIN
DE000A0JK2A8.
To find out more, visit www.aureliusinvest.de.
CONTACT
Anke Banaschewski
Investor Relations & Corporate Communications
Phone [phone] - 0
Fax [phone] - 55
[e-mail]




---------------------------------------------------------------------

01.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


280330 01.08.2014